Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in infants: a phase 2, randomised, double-blind, active-controlled trial in Guinea and Sierra Leone - Concepedia

Concepedia

Publication | Open Access

Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in infants: a phase 2, randomised, double-blind, active-controlled trial in Guinea and Sierra Leone

DOI Full Paper Access

12

Citations

15

References

2023

Year

E Choi, Boris Lacarra, Muhammed O. Afolabi, Boni Maxime Ale, Frank Baiden, Christine Bétard, Julie Foster, Benjamin Hamzé, Christine Schwimmer, Daniela Manno,

The Lancet Global Health

Abstract

For the French translation of the abstract see Supplementary Materials section.

References

	Year	Citations

Page 1